the aid library

LIST OPTIONS

Filter

10935

Download (1375)

View PDF (1560)

Basic Epidemiology

Bonita, R.; R.Beaglehole, and T. Kjellström World Health Organization WHO (2006) C_WHO

2nd edition

Download (345)

View PDF (456)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (2355)

View PDF (2977)

Combined course on growth assessment and IYCF counselling. Participant's Manual

World Health Organization (2012) C_WHO

Download (429)

View PDF (830)

Interim Guidance for Protecting Workers from Occupational Exposure to Zika Virus

Centers for Disease Prevention and Control CDC OSHA; NIOSH (2016) C_CDC

Download (8142)

View PDF (733)

Panduan Penanganan Kanker Kandung Kemih Tipe Urotelial

Umbas, R., S. Hardjowijoto, C.A. Mochtar, et al., Indonesian Urological Association (2014) C1

Guidelines for Therapy and Management of Urothelial Urinary Bladder Cancer

Download (341)

View PDF (815)

India’s Disability Policy – Analysis of Core Concepts of Human Rights

Jessica O’Dowd, Hasheem Mannan, Joanne McVeigh (2013) C1

Download (270)

View PDF (376)

Tuberculoses à bacilles résistants : diagnostic et prise en charge

Haut Conseil de la Santé Publique (2014) C2

Lignes directrices. Collection Avis et Rapports.

Download (400)

View PDF (456)

Law establishing the Rwanda Allied Health Professions Council and determining its organisation, functioning and competence

Government of Rwanda (2013) C2

N°46/2012 of 14/01/2013 - Official Gazette n° Special of 17/01/2013 - LAW No 45/2012 OF 14/01/2013 ON ORGANISATION, FUNCTIONING AND COMPETENCE OF THE COUNCIL OF PHARMACISTS

External Link

Protecting Children with Disabilities from Violence in CBR Projects: Why We Need to Work with a Different Form of Child Protection Policy for Children with Disabilities

Marieke Boersma Disability, CBR & Inclusive Development Journal (DCIDJ) (2013) CC

Disability, CBR & Inclusive Development, [S.l.], v. 24, n. 3, p. 112-122, nov. 2013. ISSN 2211-5242 Children with disabilities encounter more violence in their lives than their peers without disability. Organisations involved in Community Based Rehabilitation (CBR) come across many cases of violen... more

Download (224)

View PDF (258)

HIV and AIDS in India

Avert (2018) C2

Download (255)

View PDF (297)

The state of the health workforce in the WHO African Region, 2021

WHO Universal Health CoverageLife Course Cluster, WHO Regional Office for Africa (2021) C_WHO

Download (197)

View PDF (309)

Planetary Health 101 Information and Resources
recommended

Panorma Perspectives (2018) CC

The Panorama Perspectives: Conversations on Planetary Health report series aims to inspire new thinking, conversations, and engagement with planetary health and other integrated concepts. Collaboration and open knowledge sharing across sectors are necessary to solve the complex global health and dev... more

Download (259)

View PDF (350)

Professionalität im "global Dorf": interkulturelle Kompetenz in der Weiterbildung

Öztürk, H. (2008) CC

urn:nbn:de:0111-pedocs-107105

Download (241)

View PDF (286)

Приоритетные аспекты изучения проблемы ТБ/ВИЧ в условиях высокой распространенности ВИЧ-инфекции и ограниченных ресурсов

Delphine Sculier, Haileyesus Getahun, Reuben Granich World Health Organization, TB HIV working group, Stop TB Partnership (2011) C_WHO

Цель этого документа – повысить уровень осознания актуальности приоритетных направлений научных исследований по проблеме ТБ/ВИЧ (то есть по тем направлениям, кот... more

Download (248)

View PDF (261)

Are persons with disabilities included in the effort to leave no-one behind? Mapping disability data in development in Asia and the Pacific

United Nations Population Fund UNFPA (2022) C1

In the region, it is estimated that there are over 650 million persons with disabilities. However, without accurate, timely and disaggregated data, countries are unable to develop effective policies and programmes, monitor the wellbeing of persons with disabilities and evaluate the equity and impact... more

Download (342)

View PDF (341)

The Global Status Report on Preventing Violence Against Children 2020

UNICEF WHO (2020) C_WHO

As this report shows, reports of child abuse and of children witnessing violence between their parents and caregivers have increased. Ending violence against children is increasingly within our reach. D

Download (164)

View PDF (169)

Использование методов визуализации органов грудной клетки при COVID-19 : краткое руководство

World Health Organization WHO (2020) C_WHO

В этом Кратком руководстве рассматриваются фактические данные и даются рекомендации по использованию методов визуализации органов грудной клетки при оказании н... more

Download (159)

View PDF (227)

Monkeypox: Current status in West and Central Africa

World Health Organization (WHO) (2018) C_WHO

Monkeypox is an emerging viral zoonosis with symptoms similar to those observed in smallpox patients, although less severe. Since the global eradication of smallpox in 1980, monkeypox has emerged as the most important orthopoxvirus in humans. The Advisory Committee on Variola Virus Research (ACVVR) ... more

Download (232)

View PDF (292)

Ökonomische Bewertung in der globalen Gesundheit

Kohler, S.; N.Paul, T. Bärnighausen, P. Geldsetzer (2021) CC

In: Bonk M., Ulrichs T. (eds). Global Health: Das Konzept der Globalen Gesundheit. Berlin: De Gruyter, 2021, pp. 557–580

Download (180)

View PDF (221)

COVID-19: Vaccines Hesperian

Hesperian (2021) C1

Available in different languages

Planetary Health 101 Information and Resources recommended

Planetary Health 101 Information and Resources
recommended